Serina Therapeutics CSO Sells Full Stake After Option Exercise as Financial Strains Mount
Randall Moreadith, Chief Scientific Officer of Serina Therapeutics, sold 6,500 shares of common stock on January 28, 2026, after exercising options to acquire the same number of shares. The sale generated $23,185 at a weighted average price of $3.567 per share. The transaction coincides with recent regulatory, financial and governance developments …